Nivolumab Induced Lethal Aplastic Anemia in a Patient with Metastatic Melanoma

Nivolumab is an active treatment in patients with metastatic melanoma. We report a case of a patient with metastatic malignant melanoma who was given nivolumab as an advanced-line treatment. She received nivolumab 3 mg/kg every 2 weeks for 4 cycles and developed aplastic anemia. To the best of our k...

Descripción completa

Detalles Bibliográficos
Autores principales: Rouvinov, Keren, Nalbandyan, Karen, Kozlov, Victor, Peled, Nir, Yakobson, Alexander
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6381922/
https://www.ncbi.nlm.nih.gov/pubmed/30792642
http://dx.doi.org/10.1159/000495980

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6381922/
https://www.ncbi.nlm.nih.gov/pubmed/30792642
http://dx.doi.org/10.1159/000495980

Ejemplares similares